We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

89 hedge funds and large institutions have $364M invested in Aratana Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

50% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 24

10% more funds holding

Funds holding: 81 → 89 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less capital invested

Capital invested by funds: $396M → $364M (-$31.9M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $48K

Holders
89
Holders Change
+8
Holders Change %
+9.88%
% of All Funds
2.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
36
Reduced
24
Closed
9
Calls
–
Puts
$48K
Net Calls
-$48K
Net Calls Change
-$48K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$14.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$12.1M
3
Jennison Associates
Jennison Associates
New York
+$7.5M
4
BFA
BlackRock Fund Advisors
California
+$5.34M
5
AP
Alydar Partners
Massachusetts
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
-$9.84M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.26M
3
William Blair & Company
William Blair & Company
Illinois
-$4.41M
4
HCMT
Highland Capital Management (Texas)
Texas
-$4.25M
5
DCM
Driehaus Capital Management
Illinois
-$2.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
AP
26
Alydar Partners
Massachusetts
$2.81M +$2.55M +180,000 New
GPGA
27
Grandeur Peak Global Advisors
Utah
$2.81M +$706K +49,800 +38%
HHC
28
Hutchin Hill Capital
New York
$2.72M +$341K +24,088 +16%
VAM
29
Visium Asset Management
New York
$2.42M -$1.42K -100 -0.1%
NIP
30
Nicholas Investment Partners
California
$2.2M -$1.43M -100,579 -42%
DCM
31
Driehaus Capital Management
Illinois
$2.19M -$2.85M -201,416 -59%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.11M +$759K +53,566 +65%
Northern Trust
33
Northern Trust
Illinois
$2.04M +$286K +20,207 +18%
William Blair & Company
34
William Blair & Company
Illinois
$1.71M -$4.41M -311,390 -74%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$1.67M +$176K +12,436 +13%
TCIM
36
TIAA CREF Investment Management
New York
$1.54M +$1.08M +76,262 +340%
Millennium Management
37
Millennium Management
New York
$1.53M -$28K -1,976 -2%
UOC
38
UBS O'Connor
Illinois
$1.25M +$911K +64,263 +414%
BIM
39
BlackRock Investment Management
Delaware
$1.09M +$666K +46,979 +206%
WSA
40
Wall Street Associates
California
$1.05M -$109K -7,700 -10%
FLAM
41
First Light Asset Management
Minnesota
$815K +$42.1K +2,971 +6%
GPCM
42
Granite Point Capital Management
Massachusetts
$781K +$709K +50,000 New
TC
43
TFS Capital
Pennsylvania
$763K +$452K +31,916 +188%
Charles Schwab
44
Charles Schwab
California
$717K +$650K +45,900 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$696K +$428K +30,200 +210%
TA
46
Teachers Advisors
New York
$541K +$310K +21,863 +171%
ARC
47
Absolute Return Capital
Massachusetts
$517K +$470K +33,141 New
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
$500K -$693K -48,876 -60%
Mariner
49
Mariner
Kansas
$458K – – –
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$456K +$2.83K +200 +0.7%
1
2
3 4

PETX Hedge Fund Activity: Q2 2014 in Review

89 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q2 2014, worth a combined $364M — down 8.1% from $396M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PETX positions and 9 closed out — a net gain of 8 holders — while 36 added to existing stakes and 24 trimmed.

The largest buyer was Franklin Resources, adding an estimated $14.9M. The largest seller was MPM Asset Management, cutting an estimated $9.84M.

  • 89 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q2 2014, up from 81 in Q1 2014.
  • Funds reported $364M of Aratana Therapeutics, Inc. stock for Q2 2014, down 8.1% quarter-over-quarter.
  • 17 funds opened new Aratana Therapeutics, Inc. positions in Q2 2014 and 9 closed out, a net change of +8 holders.
  • The largest Aratana Therapeutics, Inc. buyer in Q2 2014 was Franklin Resources, an estimated $14.9M added.
  • The largest Aratana Therapeutics, Inc. seller in Q2 2014 was MPM Asset Management, an estimated $9.84M sold.

Based on aggregated 13F filings for Q2 2014.